These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 28724379)

  • 21. 18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers.
    Palaskas N; Larson SM; Schultz N; Komisopoulou E; Wong J; Rohle D; Campos C; Yannuzzi N; Osborne JR; Linkov I; Kastenhuber ER; Taschereau R; Plaisier SB; Tran C; Heguy A; Wu H; Sander C; Phelps ME; Brennan C; Port E; Huse JT; Graeber TG; Mellinghoff IK
    Cancer Res; 2011 Aug; 71(15):5164-74. PubMed ID: 21646475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo.
    Shen CT; Wei WJ; Qiu ZL; Song HJ; Zhang XY; Sun ZK; Luo QY
    J Mol Endocrinol; 2017 Jan; 58(1):15-23. PubMed ID: 27920093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant reduction of c-Myc expression and PI3K/AKT/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt's lymphoma.
    Granato M; Rizzello C; Romeo MA; Yadav S; Santarelli R; D'Orazi G; Faggioni A; Cirone M
    Int J Biochem Cell Biol; 2016 Oct; 79():393-400. PubMed ID: 27620077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer.
    Moench R; Grimmig T; Kannen V; Tripathi S; Faber M; Moll EM; Chandraker A; Lissner R; Germer CT; Waaga-Gasser AM; Gasser M
    Oncotarget; 2016 Oct; 7(42):68749-68767. PubMed ID: 27626684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response.
    Shepherd C; Banerjee L; Cheung CW; Mansour MR; Jenkinson S; Gale RE; Khwaja A
    Leukemia; 2013 Mar; 27(3):650-60. PubMed ID: 23038273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells.
    Xu RH; Pelicano H; Zhang H; Giles FJ; Keating MJ; Huang P
    Leukemia; 2005 Dec; 19(12):2153-8. PubMed ID: 16193082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines.
    Ahn KJ; Hwang HS; Park JH; Bang SH; Kang WJ; Yun M; Lee JD
    J Nucl Med; 2009 Sep; 50(9):1525-32. PubMed ID: 19690031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity.
    Yamada K; Brink I; Bissé E; Epting T; Engelhardt R
    J Dermatol; 2005 May; 32(5):316-34. PubMed ID: 16043894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between 18F-FDG accumulation and lactate dehydrogenase A expression in lung adenocarcinomas.
    Zhou X; Chen R; Xie W; Ni Y; Liu J; Huang G
    J Nucl Med; 2014 Nov; 55(11):1766-71. PubMed ID: 25342384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis.
    Parajuli P; Tiwari RV; Sylvester PW
    Biol Pharm Bull; 2015; 38(9):1352-60. PubMed ID: 26328490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
    Rodríguez-García A; Samsó P; Fontova P; Simon-Molas H; Manzano A; Castaño E; Rosa JL; Martinez-Outshoorn U; Ventura F; Navarro-Sabaté À; Bartrons R
    FEBS J; 2017 Oct; 284(20):3437-3454. PubMed ID: 28834297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromodomains and Extra-Terminal (BET) Inhibitor JQ1 Suppresses Proliferation of Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolysis.
    Zhang MY; Liu SL; Huang WL; Tang DB; Zheng WW; Zhou N; Zhou H; Abudureheman T; Tang ZH; Zhou BS; Duan CW
    Med Sci Monit; 2020 Apr; 26():e923411. PubMed ID: 32266878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y; Chen X; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of the Warburg effect in early-passage breast cancer cells.
    Robey IF; Stephen RM; Brown KS; Baggett BK; Gatenby RA; Gillies RJ
    Neoplasia; 2008 Aug; 10(8):745-56. PubMed ID: 18670636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.
    Gedaly R; Angulo P; Hundley J; Daily MF; Chen C; Evers BM
    J Surg Res; 2012 Aug; 176(2):542-8. PubMed ID: 22261591
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Dockx Y; Vangestel C; De Bruycker S; Van den Wyngaert T; Huizing M; Staelens S; Stroobants S
    Cancer Biother Radiopharm; 2023 Feb; 38(1):51-61. PubMed ID: 36472460
    [No Abstract]   [Full Text] [Related]  

  • 37. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
    Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
    PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the ROS/PI3K/AKT/HIF-1α/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2-Deoxy-d-glucose.
    Zhang T; Zhu X; Wu H; Jiang K; Zhao G; Shaukat A; Deng G; Qiu C
    J Cell Mol Med; 2019 May; 23(5):3711-3723. PubMed ID: 30920152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of c-Myc using 10058-F4 exerts caspase-3-dependent apoptosis and intensifies the antileukemic effect of vincristine in pre-B acute lymphoblastic leukemia cells.
    Sheikh-Zeineddini N; Bashash D; Safaroghli-Azar A; Riyahi N; Shabestari RM; Janzamin E; Safa M
    J Cell Biochem; 2019 Aug; 120(8):14004-14016. PubMed ID: 30957273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth.
    Hermanto U; Zong CS; Wang LH
    Oncogene; 2001 Nov; 20(51):7551-62. PubMed ID: 11709727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.